Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus-Reference-Cited by-同舟云学术

Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus

Published:2021-01 Issue:1 Volume:21 Page:215-223
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Viúdez Antonio,Crespo Guillermo^ORCID,Gómez Dorronsoro María Luisa,Arozarena Imanol,Marín-Méndez Juan Jesús,Custodio Ana,Benavent Marta,Goñi Saioa,García-Paredes Beatriz,Hernando Jorge,Durantez Maika,Alonso Vicente,Riesco María del Carmen,López Carlos,Jiménez-Fonseca Paula,San Vicente Borja López,González-Borja Iranzu,Sevilla Isabel,Hernández-Garcia Irene,Carmona-Bayonas Alberto,Capdevila Jaume,Pérez-Sanz Jairo,García-Carbonero Rocío^ORCID,Pérez-Ricarte Leyre,Llanos Marta,Vera Ruth,De Jesús Acosta Ana

Funder

Spanish Group of Neuroendocrine Tumors

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Models of gastroenteropancreatic neuroendocrine neoplasms- current status and future directions;Detjen;Neuroendocrinology,2020

2. Pancreatic neuroendocrine tumors: primum non nocere;Editorial;Surgery,2016

3. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors;Metz;Gastroenterology,2008

4. Diabetes and pancreatic neuroendocrine tumours: which interplays, if any?;Gallo;Canc Treat Rev,2018

5. Pancreatic neuroendocrine tumors: a review of serum biomarkers, staging, and management;Ma;World J Gastroenterol,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis;Journal of Gastrointestinal Oncology;2024-04

2. Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies;Cancers;2022-02-28

3. Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis;Cancer Treatment Reviews;2021-09